Nom du produit:Methyl 2-chloro-6-methoxyisonicotinate

IUPAC Name:methyl 2-chloro-6-methoxypyridine-4-carboxylate

CAS:42521-10-8
Formule moléculaire:C8H8ClNO3
Pureté:97%
Numéro de catalogue:CM178726
Poids moléculaire:201.61

Unité d'emballage Stock disponible Prix($) Quantité
CM178726-5g in stock Ⱥƿ
CM178726-25g in stock ȡǶȡ
CM178726-100g in stock ƿƿũǶ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:42521-10-8
Formule moléculaire:C8H8ClNO3
Point de fusion:-
Code SMILES:O=C(OC)C1=CC(OC)=NC(Cl)=C1
Densité:
Numéro de catalogue:CM178726
Poids moléculaire:201.61
Point d'ébullition:281.6°C at 760 mmHg
N° Mdl:MFCD00173929
Stockage:Store at 2-8°C.

Category Infos

Pyridines
Pyridine is a six-membered heterocyclic compound containing one nitrogen heteroatom. Pyridine and piperidine are the most frequently occurring heterocyclic building blocks in drug molecules. According to incomplete statistics, there are currently more than 180 drugs containing pyridine or piperidine structure that have been marketed, nearly 1/5 of the drugs approved for marketing in recent years contain these two structures.
Pyridine | C5H5N | Pyridine Supplier/Distributor/Manufacturer - Chemenu
Pyridine,Pyridine Wholesale,Pyridine for Sale,Pyridine Supplier,Pyridine Distributor,Pyridine Manufacturer
Pyridine is a basic heterocyclic organic compound with the chemical formula C5H5N. It is structurally related to benzene, with one methine group (=CH−) replaced by a nitrogen atom. It is a highly flammable, weakly alkaline, water-miscible liquid with a distinctive, unpleasant fish-like smell.

Column Infos

Cenerimod
The S1P1 receptor, a protein that plays a pivotal role in regulating immune response, interacts with S1P, a plasma lipid mediator. Remarkably, S1P regulates an array of physiological phenomena such as angiogenesis, inflammation, immunity, cell motility, and neurotransmitter release.
Enter Cenerimod, a novel, potent, and selective S1P1 receptor modulator featuring unique signaling properties, while notably negating broncho‐ and vasoconstrictor effects. Hence, Cenerimod stands as a promising candidate in the quest for improved S1P1 receptor modulators.

Related Products